Skip to search formSkip to main contentSkip to account menu

valsartan

Known as: N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine, (S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine, N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine 
An orally active nonpeptide triazole-derived antagonist of angiotensin (AT) II with antihypertensive properties. Valsartan selectively and… 
National Institutes of Health

Related topics

Related topics

39 relations
Amlodipine / valsartanAmlodipine 10 MG / Hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet [Exforge HCT]Amlodipine 5 MG / Hydrochlorothiazide 25 MG / valsartan 160 MG Oral Tablet [Exforge HCT]Angiotensin 2 Receptor Antagonists [MoA]

Broader (2)

Angiotensin II Type 1 Receptor BlockersAntihypertensive Agents

Narrower (10)

ByvalsonCGP 48933DiovanEntresto

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Chronotherapeutic drug delivery for early morning surge in blood pressure: a programmable delivery system.
2008
2008
ACE inhibitors in cardiovascular disease--unbeatable?
The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET, NCT00153101), reported by Yusuf… 
2008
2008
RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy.
Highly Cited
2006
Highly Cited
2006
AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling.
2006
2006
Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine.
Highly Cited
2000
Highly Cited
2000
A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
OBJECTIVE To compare the antihypertensive efficacy and tolerability of telmisartan 80 mg with valsartan 80 mg throughout a 24 h… 
Highly Cited
1999
Highly Cited
1999
Dose-response efficacy of valsartan, a new angiotensin II receptor blocker
Objective: To study the efficacy and tolerability of a range of valsartan doses in patients with mild-to-moderate hypertension… 
Highly Cited
1998
Highly Cited
1998
Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy
Objective: This study compares the antihypertensive efficacy and tolerability of valsartan, a novel angiotensin II antagonist… 
Highly Cited
1997
Highly Cited
1997
Valsartan, a New Angiotensin II Receptor Antagonist: A Double‐Blind Study Comparing the Incidence of Cough with Lisinopril and Hydrochlorothiazide
The present study compares the occurrence of a dry, persistent cough with doses of 80 mg of valsartan, 10 mg of lisinopril, or 25… 
Highly Cited
1984
Highly Cited
1984
Photoaffinity labeling of mammalian alpha 1-adrenergic receptors. Identification of the ligand binding subunit with a high affinity radioiodinated probe.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)